folder

Rewired type I IFN signaling is linked to age-dependent differences in COVID-19

Authors

  • Lev Petrov
  • Sophia Brumhard
  • Sebastian Wisniewski
  • Philipp Georg
  • David Hillus
  • Anna Hiller
  • Rosario Astaburuaga-García
  • Nils Blüthgen
  • Emanuel Wyler
  • Katrin Vogt
  • Hannah-Philine Dey
  • Saskia von Stillfried
  • Christina Iwert
  • Roman D. Bülow
  • Bruno Märkl
  • Lukas Maas
  • Christine Langner
  • Tim Meyer
  • Jennifer Loske
  • Roland Eils
  • Irina Lehmann
  • Benjamin Ondruschka
  • Markus Ralser
  • Jakob Trimpert
  • Peter Boor
  • Sammy Bedoui
  • Christian Meisel
  • Marcus A. Mall
  • Victor M. Corman
  • Leif Erik Sander
  • Jobst Röhmel
  • Birgit Sawitzki

Journal

  • Cell Reports Medicine

Citation

  • Cell Rep Med 6 (8): 102285

Abstract

  • Advanced age is the most important risk factor for severe disease or death from COVID-19, but a thorough mechanistic understanding of the molecular and cellular underpinnings is lacking. Multi-omics analysis of 164 samples from SARS-CoV-2-infected persons aged 1 to 84 years reveals a rewiring of type I interferon (IFN) signaling with a gradual shift from signal transducer and activator of transcription 1 (STAT1) to STAT3 activation in monocytes, CD4(+) T cells, and B cells with increasing age. Diversion of IFN signaling is associated with increased expression of inflammatory markers, enhanced release of inflammatory cytokines, and delayed contraction of infection-induced CD4(+) T cells. A shift from IFN-responsive germinal center B (GCB) cells toward CD69(high) GCB and atypical B cells during aging correlates with immunoglobulin (Ig)A production in children, whereas complement-fixing IgG predominates in adults. Our data provide a mechanistic basis for inflammation-prone responses to infections and associated pathology during aging.


DOI

doi:10.1016/j.xcrm.2025.102285